|

Hormone replacement therapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Beijing Tiantan Hospital1

Indications

  • Pituitary Neuroendocrine Tumor1
  • Pituitary Adenoma1
  • Cancer1

Other1 trial

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.